DETECTION OF ANTI-BORRELIA-BURGDORFERI ANTIBODY-RESPONSES WITH THE BORRELIACIDAL ANTIBODY-TEST, INDIRECT FLUORESCENT-ANTIBODY ASSAY PERFORMED BY FLOW-CYTOMETRY, AND WESTERN IMMUNOBLOTTING
Jr. Creson et al., DETECTION OF ANTI-BORRELIA-BURGDORFERI ANTIBODY-RESPONSES WITH THE BORRELIACIDAL ANTIBODY-TEST, INDIRECT FLUORESCENT-ANTIBODY ASSAY PERFORMED BY FLOW-CYTOMETRY, AND WESTERN IMMUNOBLOTTING, Clinical and diagnostic laboratory immunology, 3(2), 1996, pp. 184-190
Borreliacidal antibodies participate in the resolution of Lyme disease
by clearing Borrelia burgdorferi sensu late from the host. Detection
of borreliacidal antibodies is also valuable for determination of the
specific serodiagnosis of Lyme disease. We show in this work that anti
body detected by the borreliacidal antibody test did not correlate wit
h antibody detected by the indirect fluorescent-antibody assay or West
ern immunoblotting. Detection of borreliacidal antibody decreased with
elimination of the spirochete from the host in the presence or absenc
e of therapy. By contrast, the antibody responses detected by the indi
rect fluorescent-antibody assay or Western immunoblotting remained ele
vated or continued to expand, respectively. This suggests that the bor
reliacidal antibody test is a prognostic indicator for clearance of th
e spirochete. Additional investigations with humans are needed to conf
irm the prognostic potential of the borreliacidal antibody test.